Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.555
+0.055 (3.67%)
At close: Aug 13, 2025, 4:00 PM
1.560
+0.005 (0.32%)
After-hours: Aug 13, 2025, 4:10 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $251.83 million as of August 13, 2025. Its market cap has decreased by -87.76% in one year.
Market Cap
251.83M
Enterprise Value
54.20M
1-Year Change
-87.76%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $251.83M, a decrease of -90.25%. That is a compound annual growth rate of -70.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 242.92M | -85.82% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |